FAC Explorer
Audits
Audits
Findings
Corrective Action Plans
Auditors
Federal Awards
Debarment Checks
Blog
2 CFR 200
2 CFR Explained
Findings Analysis
Login
Register
Audits
Audits
Findings
Corrective Action Plans
Auditors
Federal Awards
Debarment Checks
Blog
2 CFR 200
2 CFR Explained
Findings Analysis
More
Organizations
Segments
Contacts
Docs
Account
Login
Register
Dashboard
Findings
Finding 1176719
Finding 1176719
(2024-003)
Material Weakness
Repeat Finding
Requirement
L
Questioned Costs
-
Year
2024
Accepted
2026-03-06
Audit:
390626
Organization:
National Institute for Pharmaceutical Technology and Education, Inc.
(MN)
Auditor:
BWK ROGERS PC
Finding Text
No text available
Categories
No categories assigned yet.
Other Findings in this Audit
1176720
2024-003
Material Weakness
Repeat
Programs in Audit
ALN
Program Name
Expenditures
93.103
Food and Drug Administration Research
$712,681
47.041
Engineering
$46,368